ClinVar Miner

Submissions for variant NM_001110556.2(FLNA):c.1621G>A (p.Glu541Lys)

gnomAD frequency: 0.00004  dbSNP: rs743546
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000200807 SCV000250441 likely benign not provided 2020-12-31 criteria provided, single submitter clinical testing In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge
Ambry Genetics RCV002315603 SCV000739070 likely benign Familial thoracic aortic aneurysm and aortic dissection 2018-12-18 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Invitae RCV002228873 SCV000824365 likely benign Heterotopia, periventricular, X-linked dominant; Melnick-Needles syndrome; Oto-palato-digital syndrome, type II; Frontometaphyseal dysplasia 2023-11-03 criteria provided, single submitter clinical testing
Johns Hopkins Genomics, Johns Hopkins University RCV001804931 SCV002051782 likely benign Intestinal pseudoobstruction, neuronal, chronic idiopathic, X-linked 2021-11-16 criteria provided, single submitter clinical testing
Mayo Clinic Laboratories, Mayo Clinic RCV000200807 SCV002541776 uncertain significance not provided 2021-04-14 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV003417707 SCV004117220 uncertain significance FLNA-related condition 2022-09-07 criteria provided, single submitter clinical testing The FLNA c.1621G>A variant is predicted to result in the amino acid substitution p.Glu541Lys. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.016% of alleles in individuals of African descent in gnomAD, including four hemizygous individuals (http://gnomad.broadinstitute.org/variant/X-153593574-C-T). Although we suspect this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.